Simplex Trading
APRE icon

Simplex Trading’s Aprea Therapeutics APRE Stock Holding History

Simplex Trading’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-89
Closed -$2.05K – 9877
2022
Q1 		$3K Buy
+89
New +$3.65K ﹤0.01% 9650
2021
Q4 		– Sell
-199
Closed -$17.6K – 10415
2021
Q3 		$21K Buy
199
+164
+469% +$14.9K ﹤0.01% 8383
2021
Q2 		$3K Sell
35
-126
-78% -$11.6K ﹤0.01% 9580
2021
Q1 		$16K Buy
+161
New +$18.8K ﹤0.01% 7612

Other funds holding APRE

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Simplex Trading's APRE Position: Q2 2022 in Review

Simplex Trading sold out of Aprea Therapeutics (APRE) in Q2 2022, closing a stake of 89 shares — an estimated $2.05K sold.

Simplex Trading first reported a position in APRE in Q1 2021 and held it in 4 quarters. The position peaked at $21K in Q3 2021. 33 funds tracked by Wall St. Rank hold APRE as of Q2 2022.

  • Simplex Trading reported no remaining Aprea Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Simplex Trading sold 89 Aprea Therapeutics shares in Q2 2022, an estimated $2.05K.
  • Simplex Trading first reported a position in Aprea Therapeutics in Q1 2021 and held it in 4 quarters.
  • Simplex Trading's Aprea Therapeutics position peaked at $21K in Q3 2021.
  • 33 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.